TrialInflammatory bowel diseases2021

Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study.

Daniel Aguilar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.